Canadian Manufacturing

CanAm Scientific now offering a rapid test for monkeypox

by CM Staff   

Exporting & Importing Manufacturing Operations Regulation Risk & Compliance Sales & Marketing Manufacturing marketing medical manufacturing sales Technology


In addition to Monkeypox, the M10 Analyzer is able to differentiate between Influenza, RSV and Covid-19, and can diagnosis infections such as TB, HPV, C. Difficile and Arbovirus.

CANAM SCIENTIFIC OFFERS THE WORLD’S FIRST RAPID TEST FOR MONKEYPOX (CNW Group/CanAm Scientific)

TORONTO — CanAm Scientific, a Canadian Company, and SD Biosensor, a Rapid Test Analyzers and Cassettes manufacturer, has introduced their Rapid M10 Analyzer for the detection of infectious diseases, including Monkeypox. It’s a point-of-care modular and scalable system that automatically extracts and amplifies nucleic acids for molecular diagnosis (LAMP and Real-time PCR), providing results in 1 hour versus days. CanAm Scientific says it is the world’s only rapid Monkeypox test that is able to differentiate clades.

CanAm Scientific CEO, Anthony Travonti, says that “The World Health Organization has declared Monkeypox a public health emergency of international concern. It is only a matter of time before it is declared endemic in Canada, based on rising cases.”

The WHO states that “surveillance and rapid identification of new cases are critical for outbreak containment.” Mr. Travonti has identified that currently, in Ontario, Monkeypox testing is performed only through the Toronto Public Health facility. Test results are available 2 to 3 days following receipt of the specimen. “As we’ve experienced with Covid-19, as case numbers and testing increase, so will the length of time it takes to report a result.”

Health Canada states that “efforts are focused on containment of the outbreak and the prevention of further spread.” This means immediate isolation of those infected and contact tracing of those identified as at-risk contacts. “The sooner an infection is determined (and isolated), and the sooner at-risk contacts can be traced, notified, and isolated, then the more excellent the opportunity for containment.”, reasons Mr. Travonti.

Advertisement

In addition to Monkeypox, the M10 Analyzer is able to differentiate between Influenza, RSV and Covid-19, and can diagnosis infections such as TB, HPV, C. Difficile and Arbovirus. SD Biosensor is working on expanding their list of diagnostics specifically for the M10, and will continue to pursue in-vitro diagnostic testing for which quantitative and qualitative analysis of illnesses are possible. The M10 is currently not for sale in Canada, but will be released in the near future.

Advertisement

Stories continue below

Print this page

Related Stories